Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elbasvir/Grazoprevir in Hemodialysis Patients with Chronic Hepatitis C
NCT03022006Phase 4Unknown
- Sponsor
- NORTE Study Group
- Start
- Jan 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of elbasvir, grazoprevir in hepatitis C (HCV), sponsored by NORTE Study Group. Status: unknown.
02
Drugs
elbasvirgrazoprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03022006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03022006.